Literature DB >> 10606049

Striking increase of thin melanomas contrasts with stable incidence of thick melanomas.

D M Lipsker1, G Hedelin, E Heid, E M Grosshans, B J Cribier.   

Abstract

OBJECTIVE: The aim of this study was to analyze the temporal evolution of melanoma incidence in the department of the Bas-Rhin, France, and to study the evolution of tumor thickness.
DESIGN: Retrospective study including all histologically proven melanomas recorded at the cancer registry of the department of the Bas-Rhin between January 1980 and December 1992 and at the Cutaneous Histopathology Department of the University Hospitals, Strasbourg, between January 1980 and December 1997.
SETTING: Population-based cancer registry and academic cutaneous histopathology department. PATIENTS: A total of 1254 patients with histologically proven melanomas. INTERVENTION: None. MAIN OUTCOME MEASURES: Temporal evolution of melanoma incidence and tumor thickness.
RESULTS: The mean (SD) and median tumor thicknesses were 1.48 (1.59) mm and 0.87 mm, respectively, and they decreased during the study period. The increase in the number of melanomas was mainly related to an increase of superficial spreading melanomas in both sexes. The number of intermediate melanomas (1-2 mm) in both sexes and the number of melanomas with a Breslow index between 2 and 4 mm in women increased only slightly. The number of melanomas with a Breslow index greater than 2 mm in men and greater than 4 mm in women remained stable during the reference period.
CONCLUSION: A striking increase in incidence of thin melanomas contrasts with a stable incidence of thick melanomas.

Entities:  

Mesh:

Year:  1999        PMID: 10606049     DOI: 10.1001/archderm.135.12.1451

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

Review 1.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

Review 2.  A new understanding in the epidemiology of melanoma.

Authors:  Esther Erdei; Salina M Torres
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

3.  Incidence of childhood and adolescent melanoma in the United States: 1973-2009.

Authors:  Jeannette R Wong; Jenine K Harris; Carlos Rodriguez-Galindo; Kimberly J Johnson
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

4.  Only superficial spreading melanoma is causing the melanoma epidemics?

Authors:  E Crocetti; P Carli
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.

Authors:  C Monteagudo; J M Martin; E Jorda; A Llombart-Bosch
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

6.  Ambulatory melanoma care patterns in the United States.

Authors:  Andrew L Ji; Michael R Baze; Scott A Davis; Steven R Feldman; Alan B Fleischer
Journal:  J Skin Cancer       Date:  2013-08-21

7.  13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.

Authors:  D M Parkin; D Mesher; P Sasieni
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

8.  The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.

Authors:  J Melia; S Moss; D Coleman; T Frost; R Graham-Brown; J A Hunter; R A Marsden; A du Vivier; A P Warin; J White; S M Whitehead; M A Wroughton
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

9.  Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.

Authors:  Stephanie E Johnson-Obaseki; Varant Labajian; Martin J Corsten; James T McDonald
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-12-02

10.  Increasing melanoma awareness among health and social care professionals in secondary care in an era of reduced skin cancer referrals due to COVID-19.

Authors:  C Quinlan; R Gill; M Murphy
Journal:  Clin Exp Dermatol       Date:  2020-07-22       Impact factor: 4.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.